Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Hall, Steven E"'
Autor:
Fadden, Patrick, Huang, Kenneth H., Veal, James M., Steed, Paul M., Barabasz, Amy F., Foley, Briana, Hu, Mei, Partridge, Jeffrey M., Rice, John, Scott, Anisa, Dubois, Laura G., Freed, Tiffany A., Silinski, Melanie A. Rehder, Barta, Thomas E., Hughes, Philip F., Ommen, Andy, Ma, Wei, Smith, Emilie D., Spangenberg, Angela Woodward, Eaves, Jeron, Hanson, Gunnar J., Hinkley, Lindsay, Jenks, Matthew, Lewis, Meredith, Otto, James, Pronk, Gijsbertus J., Verleysen, Katleen, Haystead, Timothy A., Hall, Steven E.
Publikováno v:
In Chemistry & Biology 2010 17(7):686-694
Autor:
Hall, Steven E.
Publikováno v:
In Drug Discovery Today 2006 11(11):495-502
Objective: To compare relapse rates and healthcare costs in MS patients treated with Glatopa 20 mg (generic glatiramer acetate) versus Copaxone 20 mg in a US managed care population. Methods: A retrospective claims study was conducted using the Healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c3370dffa1b158a1100bbc42b7a187
Autor:
Richard Sachleben, James Roach, Tanmoy Ganguly, Benjamin Greenberg, Jonathan C. Lansing, Daniel Kantor, Ian Fier, James H. Prescott, Hall Steven E, Christine Bell, Paul J. Miller, Kavita V. Nair, Kristina Storey, Ishan Capila, Joseph Glajch, James M. Anderson, Mani Iyer
Publikováno v:
Journal of pharmacy practice, vol 31, iss 5
The multiple sclerosis (MS) treatment landscape in the United States has changed dramatically over the past decade. While many disease-modifying therapies (DMTs) have been approved by the US Food and Drug Administration (FDA) for the treatment of rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca70b152ba0ebfb57b69915a776b609b
https://escholarship.org/uc/item/8k30d36z
https://escholarship.org/uc/item/8k30d36z
Autor:
Healy, Vicki L, Mullins, Leisha S *, Li, Xianfeng, Hall, Steven E, Raushel, Frank M, Walsh, Christopher T *
Publikováno v:
In Chemistry & Biology 1 July 2000 7(7):505-514
Autor:
Huang, Kenneth H., Barta, Thomas E., Rice, John W., Smith, Emilie D., Ommen, Andy J., Ma, Wei, Veal, James M., Fadden, R. Patrick, Barabasz, Amy F., Foley, Briana E., Hughes, Philip F., Hanson, Gunnar J., Markworth, Christopher J., Silinski, Melanie, Partridge, Jeffrey M., Steed, Paul M., Hall, Steven E.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1 April 2012 22(7):2550-2554
Autor:
Wen-Ching Han, Baerbel R. Brown, Hall Steven E, Harold Goldenberg, Joel C. Barrish, Raj N. Misra, Don N. Harris, Manorama Patel, Philip M. Sher, O. Kocy
Publikováno v:
Journal of Medicinal Chemistry. 36:1401-1417
A series of interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles (2) were prepared and evaluated for their thromboxane (TxA2) antagonistic activity in vitro and duration of action in vivo. Examination of the carboxyl side chain indicated that the inter
Autor:
Hall Steven E, Guy C. Le Breton, T Lim Chang, Dimitri Komiotis, Stephen C.-T. Lam, Kim Sun-Ok, Duane L. Venton
Publikováno v:
Biochemical Pharmacology. 43:313-322
The human platelet thromboxane A2/prostaglandin H2 receptor has been purified 6100-fold to apparent homogeneity by a three-step chromatographic procedure with an overall yield of 6%. A 6-fold purification of the receptor was first achieved by chromat